Lymphoma immunotherapy to train the body to fight bad B-cells like viruses ... MedCity News Currently approved biologics for lymphoma include Rituximab (Genentech), Ibritumomab tuixetan (Spectrum Pharmaceuticals) and Tositumomab (GSK), which are part of a larger lymphoma drug market expected to double between 2011 and 2019. Formed in ... |
